The Range of 2.2-3.3 mg/gCr of Pregnanetriol in the First Morning Urine Sample as an Index of Optimal Control in CYP21 Deficiency-Reference-Cited by-同舟云学术

The Range of 2.2-3.3 mg/gCr of Pregnanetriol in the First Morning Urine Sample as an Index of Optimal Control in CYP21 Deficiency

Published:2008 Issue:3 Volume:17 Page:75-80
ISSN:0918-5739
Container-title:Clinical Pediatric Endocrinology
language:en
Short-container-title:Clin Pediatr Endocrinol

Author:

Izawa Masako¹,Aso Keiko¹,Higuchi Asako¹,Ariyasu Daisuke¹,Hasegawa Yukihiro¹

Affiliation:

1. Division of Endocrinology and Metabolism, Tokyo Metropolitan Kiyose Children's Hospital

Publisher

Japanese Society for Pediatric Endocrinology

Subject

Endocrinology,Endocrinology, Diabetes and Metabolism,Pediatrics, Perinatology, and Child Health

Link

http://www.jstage.jst.go.jp/article/cpe/17/3/17_3_75/_pdf

Reference11 articles.

1. 1. Paul MS. The adrenal cortex. In: Larsen PR, Kronenberg HM, Melmed S, Polonsky KS, editors. Wiliams textbook of endocrinology. 10^th ed, Philadelphia: WB Saunders; 2002. p.491-551.

2. 3. Appan S, Hindmarsh PC, Brook CGD. Monitoring treatment in congenital adrenal hyperplasia. Arch Dis Child 1989;64:1235-9.

3. 4. Einaudi S, Lala R, Corrias A, Matarazzo P, Pagliardini S, Sanctis C. Auxological and biochemical parameters in assessing treatment of infants and toddlers with congenital adrenal hyperplasia due to 21-hydroxylase deficiency. J Pediatr Endocrinol 1993;6:173-8.

4. 5. Bailey CC, Komrower GM, Palmer M. Management of congenital adrenal hyperplasia. Arch Dis Child 1978;53:132-5.

Cited by 10 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Biochemical monitoring of 21-hydroxylase deficiency: a clinical utility of overnight fasting urine pregnanetriol;Current Opinion in Pediatrics;2024-05-31

2. Monitoring treatment in pediatric patients with 21-hydroxylase deficiency;Frontiers in Endocrinology;2023-02-03

3. Current and future perspectives on clinical management of classic 21-hydroxylase deficiency;Endocrine Journal;2023

4. Steroids in urine, other fluids and tissues;Steroids in the Laboratory and Clinical Practice;2023

5. Hypergonadism;Steroids in the Laboratory and Clinical Practice;2023